Biochemical markers and force cardiovascular test on metabolic syndrome

被引:0
|
作者
Cabezas, Gloria [1 ]
Lares, Mary [2 ,3 ]
Velasco, Manuel [4 ]
Rodriguez, Hilda [1 ]
Albiarez, Irene [5 ]
Hernandez, Pablo [2 ]
Mendoza, Freddy [1 ]
Melero, Jesus [3 ]
机构
[1] Univ Cent Venezuela, Escuela Med Jose M Vargas, Lab Func Cardiopulm & Ejercicio, Caracas, Venezuela
[2] Univ Cent Venezuela, Fac Med, Escuela Nutr & Dietet, Caracas, Venezuela
[3] Hosp Militar Dr Carlos Arvelo, Caracas, Venezuela
[4] UCV, Escuela Med Jose Maria Vargas, Unidad Farmacol Clin, Caracas, Venezuela
[5] Unidad Educ Nacl Jose Felix Ribas, San Juan Morros, Venezuela
来源
关键词
Metabolic syndrome; cardiovascular risk; endothelial markers;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The metabolic syndrome (MS) has endothelial dysfunction, and an abnormal release of endothelial markers, such as: Nitric Oxide (NO) and endothelin-I (EI). Exercise is a physiological stress regulated by the CNS, and its effects on the release of endothelial markers in the MS have not been well studied. The goal of the study was to measure levels of NO and IE in blood of people with MS; during they were exercising, and compared with normal individuals. In order to perform the study 50 people, of both sexes, with MS and 50 normal were selected. They history, physical examination, anthropometrics, echocardiography, lipid profile and basal insulin were determined. It was also performed: stress test (measured continuously), and simultaneously was took electrocardiogram, blood pressure, O2 saturation, [maximal oxygen consumption, ventilation (V) and anaerobic threshold (UAN]. The blood samples were taken for the ON and EI determination at the beginning, after UAN and to the completion of the test. The determination of mean +/- standard deviation was performed using the statistical package SPSS version 19, a one-way ANOVA was performed with statistical significance at p < 0.05. It was observed a decreasing of the nitric oxide and a non significant increasing of the endothelin-1 with statistical significance p < 0.05 as a result of the stress test in those patients diagnosed with metabolic syndrome. These results could be an early marker that can be used in patients during its exercise, as a possible predictor of cardiovascular risk.
引用
收藏
页码:1 / 5
页数:5
相关论文
共 50 条
  • [21] Impacts of food consumption on biochemical markers and anthropometric variables of women with metabolic syndrome
    Michalichen, Kelly Cristiane
    Reis Weber, Vinicius Muller
    Queiroga, Marcos Roberto
    Fernandes, Daniel Zanardini
    Carreira, Clisia Mara
    Vieira, Edgar Ramos
    Venturini, Danielle
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [22] Biochemical markers of psoriasis as a metabolic disease
    Gerkowicz, Agnieszka
    Pietrzak, Aldona
    Szepietowski, Jacek Cezary
    Radej, Sebastian
    Chodorowska, Grazyna
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2012, 50 (02) : 155 - 170
  • [23] Markers of cardiovascular disease risk following weight loss in men with metabolic syndrome
    Gregory, Sara Michelle
    Headley, Samuel A. E.
    Matthews, Tracey
    Alaimo, Danielle
    Hope, Crystal
    Hoyt, Shawn
    Manie, Katie
    Sawyer, Jason
    Lusciano, Kristen
    Wood, Richard J.
    FASEB JOURNAL, 2011, 25
  • [24] The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health
    Oben, Julius
    Enonchong, Ebangha
    Kuate, Dieudonne
    Mbanya, Dora
    Thomas, Tiffany C.
    Hildreth, DeWall J.
    Ingolia, Thomas D.
    Tempesta, Michael S.
    LIPIDS IN HEALTH AND DISEASE, 2007, 6 (1)
  • [25] Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome
    Prats-Puig, Anna
    Osiniri, Ines
    Soriano-Rodriguez, Pilar
    Carreras-Badosa, Gemma
    Cristobal Bunuel-Alvarez, Jose
    Vila-Pablos, Carmen
    de Zegher, Francis
    Ibanez, Lourdes
    Bassols, Judit
    Lopez-Bermejo, Abel
    ATHEROSCLEROSIS, 2014, 233 (01) : 272 - 277
  • [26] The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular health
    Julius Oben
    Ebangha Enonchong
    Dieudonne Kuate
    Dora Mbanya
    Tiffany C. Thomas
    DeWall J. Hildreth
    Thomas D. Ingolia
    Michael S. Tempesta
    Lipids in Health and Disease, 6
  • [27] Markers of inflammation and fibrosis are related to cardiovascular damage in hypertensive patients with metabolic syndrome
    Sciarretta, Sebastiano
    Ferrucci, Andrea
    Ciavarella, Giuseppino Massimo
    De Paolis, Paola
    Venturelli, Vanessa
    Tocci, Giuliano
    De Biase, Luciano
    Rubattu, Speranza
    Volpe, Massimo
    AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (07) : 784 - 791
  • [28] Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
    Ozdemir, Suna
    Ozdemir, Mustafa
    Gorkemli, Huseyin
    Kiyici, Aysel
    Bodur, Sait
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2010, 89 (02) : 199 - 204
  • [29] Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome
    O'Sullivan, Aifric
    Gibney, Michael J.
    Connor, Aine O.
    Mion, Brian
    Kaluskar, Soniya
    Cashman, Kevin D.
    Flynn, Albert
    Shanahan, Fergus
    Brennan, Lorraine
    MOLECULAR NUTRITION & FOOD RESEARCH, 2011, 55 (05) : 679 - 690
  • [30] The "biochemical" metabolic syndrome in paediatrics
    Martín-Lázaro, JF
    Bueno, G
    Becerra, A
    Moreno, LA
    Tresaco, B
    Garagorri, J
    Lázaro, A
    INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S129 - S129